Observational study

Frontera J.A., Sabadia S., Lalchan R., et al. (2020) A Prospective Study of Neurologic Disorders in Hospitalized COVID-19 Patients in New York City. Neurology Oct 2020, 10.1212/WNL.0000000000010979; DOI: 10.1212/WNL.0000000000010979

Alexopoulos H., Magira E., Bitzogli K., et al. (2020)  Anti–SARS-CoV-2 antibodies in the CSF, blood-brain barrier dysfunction, and neurological outcome. Studies in 8 stuporous and comatose patients. Neurol Neuroimmunol Neuroinflamm 2020;7:e893. doi:10.1212/NXI.0000000000000893

Guilmot A, Maldonado Slootjes S, Sellimi A, et al. Immune-mediated neurological syndromes in SARS-CoV-2-infected patients [published online ahead of print, 2020 Jul 30]. J Neurol. 2020;1-7. doi:10.1007/s00415-020-10108-x

Pilotto et al. The clinical spectrum of encephalitis in COVID-19 disease: the ENCOVID multicentre studyMedRxiv (preprint). https://doi.org/10.1101/2020.06.19.20133991

Paterson RW, Brown RL, Benjamin L. et al. The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings, Brain, , awaa240, doi.org/10.1093/brain/awaa240

Varatharaj A., Thomas N., and Ellul M., et al. (2020) UK-Wide Surveillance of Neurological and Neuropsychiatric Complications of COVID-19: The First 153 Patients. http://dx.doi.org/10.2139/ssrn.3601761

Ferrarese C., Silani V., Priori A. An Italian multicenter retrospective-prospective observational study on neurological manifestations of COVID-19 (NEUROCOVID). Neurological Sciences; 41: 1355-1359 https://doi.org/10.1007/s10072-020-04450-1

Frontera J., Mainali S., Fink E.L., et al. (2020) Global Consortium Study of Neurological Dysfunction in COVID‑19 (GCS‑NeuroCOVID): Study Design and Rationale. Neurocrit Care https://doi.org/10.1007/s12028-020-00995-3